MiMedx Group
MDXG

MiMedx Group (MDXG) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
Craig-HallumMaintainedBuy$8.00 from $6.00Aug 27, 2026
Cantor FitzgeraldMaintainedOverweight$8.00Aug 17, 2026
CitizensMaintainedMarket Outperform$6.00 from $7.00Apr 30, 2026
CitizensMaintainedMarket Outperform$7.00 from $10.00Apr 20, 2026
Craig-HallumMaintainedBuy$7.00 from $10.00Apr 17, 2026
CitizensInitiated CoverageMarket Outperform$10.00Feb 23, 2026
Cantor FitzgeraldMaintainedOverweight$8.00 from $12.00Feb 17, 2026
Lake StreetMaintainedBuy$10.00 from $12.00Jan 20, 2026
MizuhoMaintainedOutperform$10.00 from $12.00Dec 17, 2025
Cantor FitzgeraldMaintainedOverweight$12.00 from $11.00Jul 31, 2025
Cantor FitzgeraldMaintainedOverweight$11.00Jul 15, 2025
Cantor FitzgeraldMaintainedOverweight$13.00Feb 27, 2025
Craig-HallumMaintainedBuy$12.00 from $14.00Aug 1, 2024
Cantor FitzgeraldMaintainedOverweight$11.00Aug 1, 2024
Cantor FitzgeraldInitiated CoverageOverweight$11.00Jul 2, 2024
HC Wainwright & Co.MaintainedBuy$11.00May 1, 2024
MizuhoMaintainedBuy$14.00 from $13.00Mar 1, 2024
MizuhoMaintainedBuy$12.00 from $14.00Oct 31, 2023
Craig-HallumInitiated CoverageBuy$12.00Oct 27, 2023
MizuhoMaintainedBuy$12.00 from $10.00Aug 2, 2023

Frequently asked questions

  • What is the latest analyst rating on MDXG?

    On Aug 27, 2026, Craig-Hallum maintained MiMedx Group at Buy with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.